皇冠体育apprmo Fisher Scientific / Roper Technologies merger inquiry
皇冠体育app CMA investigated the anticipated acquisition by 皇冠体育apprmo Fisher Scientific Inc of the electron microscope peripherals business of Roper Technologies Inc (the Gatan business)
Phase 2
Merger reference cancelled
10 June 2019: 皇冠体育app CMA has cancelled its merger inquiry into 皇冠体育apprmo Fisher鈥檚 anticipated acquisition of the electron microscope peripherals business of Roper Technologies (Gatan)
- (10.6.19)
- News story: 皇冠体育apprmo Fisher/Roper abandon deal (10.6.19)
Response to the remedies notice
- (7.5.19)
Provisional Findings
24 April 2019: 皇冠体育app CMA has decided to extend the deadline for responses to the Notice of possible remedies to 8am GMT on Tuesday 7 May.
17 April 2019: 皇冠体育app CMA has provisionally found extensive competition concerns as part of its in-depth investigation of the proposed acquisition by 皇冠体育apprmo Fisher of the Gatan business of Roper.
- (17.4.19)
- (17.4.19)
- (17.4.19)
- (17.4.19)
- (17.4.19)
- News story: 皇冠体育apprmo Fisher鈥檚 proposed takeover of Gatan raises competition concerns (17.4.19)
Initial submissions
- (31.1.19)
Issues statement
31 January 2019: 皇冠体育app issues statement sets out the scope of the inquiry. It outlines initial theories on what might be adversely affecting competition, but it does not set out findings or conclusions. 皇冠体育app deadline for submissions on the issues statement is 10am, Tuesday 19 February 2019.
- (31.1.19)
Administrative timetable
Date of referral: 7.1.19
Statutory deadline: 23.6.19
- (21.1.19)
Inquiry group appointed
7 January 2019: 皇冠体育app CMA has appointed the inquiry group:
Martin Coleman (Chair), Humphrey Battcock, Robin Cohen and Anne Fletcher.
Terms of reference
7 January 2019: 皇冠体育app CMA has referred the anticipated acquisition by 皇冠体育apprmo Fisher Scientific Inc of the electron microscope peripherals business of Roper Technologies Inc (the Gatan business) for an in-depth investigation.
- (7.1.19)
Phase 1
Statutory timetable
Phase 1 date | Action |
---|---|
19 December 2018 | Decision announced |
24 October to 7 November 2018 | Invitation to comment |
24 October 2018 | Launch of merger inquiry |
Reference decision
7 January 2019: 皇冠体育app CMA has referred the anticipated acquisition by 皇冠体育apprmo Fisher Scientific Inc of the electron microscope peripherals business of Roper Technologies Inc (the Gatan business) for an in-depth investigation:
- (7.1.19)
Reference unless undertakings accepted
19 December 2018: 皇冠体育app CMA has decided, on the information currently available to it, that it is or may be the case that this merger has resulted or may be expected to result in a substantial lessening of competition within a market or markets in the United Kingdom. This merger will be referred for a phase 2 investigation unless the parties offer acceptable undertakings to address these competition concerns.
- (21.1.19)
- News story: 皇冠体育apprmo Fisher鈥檚 takeover of Gatan comes under CMA microscope (19.12.18)
Invitation to comment: now closed
24 October 2018: 皇冠体育app Competition and Markets Authority (CMA) is considering whether it is or may be the case that this transaction, if carried into effect, will result in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation may be expected to result in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.
Launch of merger inquiry
24 October 2018: 皇冠体育app CMA announced the launch of its merger inquiry by notice to the parties.
- (24.10.18)
Contact
Please send written representations about any competition issues to [email protected].
Updates to this page
-
皇冠体育app CMA has cancelled its merger inquiry into 皇冠体育apprmo Fisher鈥檚 anticipated acquisition of the electron microscope peripherals business of Roper Technologies (Gatan).
-
Response to remedies notice published.
-
Update: Extension to the deadline for responses to the Notice of possible remedies.
-
皇冠体育app summary of provisional findings, notice of provisional findings and notice of possible remedies have been published.
-
Issues statement and initial submission from 皇冠体育apprmo Fisher and Roper published.
-
皇冠体育app decision to refer to phase 2 has been announced and added to the case page.
-
First published.